The bioequivalence (BE) programme of CRC Sarawak General Hospital (SGH) is conducted in Sarawak General Hospital Heart Centre (SGHHC), which itself is situated about 15km away from the main hospital. The BE studies take place in the CRC Research Ward, a fully equipped clinical research ward located at Level 6 of the hospital. The clinical site is recognized by the Ministry of Health (MOH) Malaysia and was listed in the National Pharmaceutical Control Bureau Compliance Programme for Bioequivalence Centres in September 2013.
CRC SGH has developed a partnership with a Sarawak-based Contract Research Organization (CRO), Borneo Kinetics Sdn. Bhd., to complement the study activities. Between September 2013 and May 2015, the Centre has conducted 15 BE studies covering a broad spectrum of pharmaceutical products, from hypertensive to antibiotics. The CRC Research Ward is also tailored to conduct selected Phase I clinical studies.